Influence of Aromatase Inhibitors and GnRH Analogs to Treat Uterine Leiomyoma by Vaginal Hysterectomy
|ClinicalTrials.gov Identifier: NCT01280045|
Recruitment Status : Unknown
Verified May 2012 by LUIZ GUSTAVO OLIVEIRA BRITO, University of Sao Paulo.
Recruitment status was: Recruiting
First Posted : January 20, 2011
Last Update Posted : May 31, 2012
University of Sao Paulo
Information provided by (Responsible Party):
LUIZ GUSTAVO OLIVEIRA BRITO, University of Sao Paulo
No Study Results Posted on ClinicalTrials.gov for this Study
|Recruitment Status :||Unknown|
|Estimated Primary Completion Date :||May 2013|
|Estimated Study Completion Date :||January 2015|
Parsanezhad ME, Azmoon M, Alborzi S, Rajaeefard A, Zarei A, Kazerooni T, Frank V, Schmidt EH. A randomized, controlled clinical trial comparing the effects of aromatase inhibitor (letrozole) and gonadotropin-releasing hormone agonist (triptorelin) on uterine leiomyoma volume and hormonal status. Fertil Steril. 2010 Jan;93(1):192-8. doi: 10.1016/j.fertnstert.2008.09.064. Epub 2009 Jan 9.